104 related articles for article (PubMed ID: 38783429)
1. Association of podoplanin expression to histopathological grades of oral epithelial dysplasia and oral squamous cell carcinoma.
Shabir H; Durrani SH; Tariq SF; Khatak SS; Khan AS; Arbab KN
J Pak Med Assoc; 2024 May; 74(5):852-856. PubMed ID: 38783429
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of podoplanin in oral carcinomas in situ and squamous cell carcinomas.
Funayama A; Cheng J; Maruyama S; Yamazaki M; Kobayashi T; Syafriadi M; Kundu S; Shingaki S; Saito C; Saku T
Pathobiology; 2011; 78(3):171-80. PubMed ID: 21613804
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
D'souza B; Nayak R; Kotrashetti VS
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
[TBL] [Abstract][Full Text] [Related]
4. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
5. Podoplanin expression during dysplasia-carcinoma sequence in the oral cavity.
Inoue H; Miyazaki Y; Kikuchi K; Yoshida N; Ide F; Ohmori Y; Tomomura A; Sakashita H; Kusama K
Tumour Biol; 2012 Feb; 33(1):183-94. PubMed ID: 22081310
[TBL] [Abstract][Full Text] [Related]
6. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
AbdulMajeed AA; Dalley AJ; Farah CS
Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemically Detection of Angiogenesis in Oral Pre-Cancerous Lesions Compared with Oral Invasive Carcinomas.
Kargahi N; Torabinia N; Razavi SM; Tahririan D; Kamani H; Nazari M
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1805-1808. PubMed ID: 30049191
[TBL] [Abstract][Full Text] [Related]
8. Podoplanin expression in tumor-free resection margins of oral squamous cell carcinomas: an immunohistochemical and fractal analysis study.
Margaritescu C; Raica M; Pirici D; Simionescu C; Mogoanta L; Stinga AC; Stinga AS; Ribatti D
Histol Histopathol; 2010 Jun; 25(6):701-11. PubMed ID: 20376776
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization of c-Jun in normal mucosa, oral submucous fibrosis, epithelial dysplasia, and oral squamous cell carcinoma: A comparative study.
Shraddha KS; Niranjan KC; Hallikeri K
J Cancer Res Ther; 2018; 14(6):1180-1183. PubMed ID: 30488826
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical Evaluation of Glucose Transporter Type 1 in Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Pereira KM; Feitosa SG; Lima AT; Luna EC; Cavalcante RB; de Lima KC; Chaves FN; Costa FW
Asian Pac J Cancer Prev; 2016; 17(1):147-51. PubMed ID: 26838200
[TBL] [Abstract][Full Text] [Related]
11. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
12. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.
Kawaguchi H; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim E; Hong WK; Lippman SM; Mao L
J Clin Oncol; 2008 Jan; 26(3):354-60. PubMed ID: 18202409
[TBL] [Abstract][Full Text] [Related]
13. Lack of elevated HER2/neu expression in epithelial dysplasia and oral squamous cell carcinoma in Iran.
Seifi S; Shafaei SN; Nosrati K; Ariaeifar B
Asian Pac J Cancer Prev; 2009; 10(4):661-4. PubMed ID: 19827890
[TBL] [Abstract][Full Text] [Related]
14. [Podoplanin expression in oral squamous cell carcinoma and leukoplakia and its correlation with lymph vessels density].
Zhang G; Guo ZL; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Aug; 44(8):488-91. PubMed ID: 19961757
[TBL] [Abstract][Full Text] [Related]
15. Stathmin! An immunohistochemical analysis of the novel marker in Oral Squamous Cell Carcinoma and Oral Leukoplakia.
Vadla P; Yeluri S; Deepthi G; Guttikonda VR; Taneeru S; Naramala S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3317-3323. PubMed ID: 33247690
[TBL] [Abstract][Full Text] [Related]
16. A comparative analysis of langerhans cell in oral epithelial dysplasia and oral squamous cell carcinoma using antibody CD-1a.
Upadhyay J; Rao NN; Upadhyay RB
J Cancer Res Ther; 2012; 8(4):591-7. PubMed ID: 23361280
[TBL] [Abstract][Full Text] [Related]
17. Expression of CLLD7 and CHC1L Proteins in Oral Epithelial Dysplasia in a Group of Thai Patients.
Wiphakphongpakorn P; Juengsomjit R; Poomsawat S; Meesakul O; Bhattarai BP; Klongnoi B; Buajeeb W; Khovidhunkit SP
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1257-1264. PubMed ID: 38679985
[TBL] [Abstract][Full Text] [Related]
18. A correlation of immunohistochemical expression of
Pandya JA; Boaz K; Natarajan S; Manaktala N; Nandita KP; Lewis AJ
J Cancer Res Ther; 2018; 14(3):666-670. PubMed ID: 29893337
[TBL] [Abstract][Full Text] [Related]
19. Differential immunohistochemical expression profiles of perlecan-binding growth factors in epithelial dysplasia, carcinoma in situ, and squamous cell carcinoma of the oral mucosa.
Hasegawa M; Cheng J; Maruyama S; Yamazaki M; Abé T; Babkair H; Saito C; Saku T
Pathol Res Pract; 2016 May; 212(5):426-36. PubMed ID: 26965914
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Potential of N-Cadherin in Oral Squamous Cell Carcinoma via Immunohistochemical Methods.
Chandolia B; Rajliwal JP; Bajpai M; Arora M
J Coll Physicians Surg Pak; 2017 Aug; 27(8):475-478. PubMed ID: 28903838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
